Learn More
Apexbio Technology LLC JNJ-26854165 (Serdemetan), 25mg. Cas: 881202-45-5 MFCD: MFCD16620518. P53 activator, blocking Mdm2-p53 interaction

Supplier: Apexbio Technology LLC A420425
JNJ-26854165, also named as Serdemetan, is originally developed as an activator of p53, is now regarded as a novel oral Human Double Minute-2 (HDM-2) ubiquitin ligase antagonist. Other sizes are available. Please inqury us for quote.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.